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Objective:  
The purpose of this study was to  
estimate the  prevalence of renal im-
pairment for osteoporotic patients, and 
compare demographic  characteristics 
for osteoporotic patients  across level  
of renal impairment.  
Conclusion:  
Based on eGFR<35, bisphosphonate treatment would not be 
recommended in 3.6 % of osteoporotic patients due to renal 
impairment. 
 
Material and methods:  
This cohort study is based on data from the Danish national 
health registries and blood measurements of estimated Glomer-
ular Filtration Rate (eGFR) from three of five Danish regions. 
Last blood measurement of eGFR is used as index-date. 
The inclusion criteria were:  
 age ≥50 years  
 AND either diagnosed with osteoporosis  
 OR had a history of fracture  
 OR a bone mass density (BMD) t-score of lumbar spine or 
femur neck < -2.5.  
 
Stages of renal impairment ranged from normal to failure 
(KDOQI 1-5) measured by eGFR and a separate category of ‘not 
recommended for BIS treatment (eGFR <35) equivalent to some 
patients in KDOQI stage 3 and all patients in KDOQI stages 4 
and 5.  
Results:  
In total 7,336 patients were identified, of which 6,614 were 
women. The prevalence of renal failure (stage 5) amongst osteo-
porotic patients was 0.1%, and the prevalence of an eGFR<35 
(‘not recommended for BIS’) was 3.6%. The median time from 
diagnosis of osteoporosis to measurement of eGFR was 7.2±5.1 
years. 
The mean age was 72.5±10.3 years. The age increased signifi-
cantly with decreasing eGFR from 69.0±10.1 for stage 1 
(normal) to 81.5±7.6 for stage 5 (failure) patients (p<0.001). 
Weight was significantly higher for KDOQI 3 (moderate renal 
impairment, eGFR 30-59) patients (p=0.021), while BMI similar-
ly increased with decreasing eGFR (p<0.001).  
For co-morbidities diabetes was significantly associated with 
decreased eGFR (p<0.001). 
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